PREDNISONE, SRP-9003, PREDNISONE, PREDNISONE
SRP-9003-301
Phase 3 small_molecule active
Quick answer
PREDNISONE, SRP-9003, PREDNISONE, PREDNISONE for Limb-girdle muscular dystrophy, type 2E/R4 (LGMD2E/R4) or β-sarcoglycanopathy is a Phase 3 program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Limb-girdle muscular dystrophy, type 2E/R4 (LGMD2E/R4) or β-sarcoglycanopathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active